Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Browse drugs by first letter:

HOT A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Drug Monographs

N2106

N2107

N2817

N2E4

N332-GT5 gp140

N332-GT5 gp140 adjuvanted With SMNP

N4-1000

N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₃₆N_₄O_₄

N4-Hydroxycytidine

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₃N_₃O_₆

CAS Number: 3258-02-4

Unique Ingredient Identifier: C3D11PV2O4

Summary

N4-Hydroxycytidine is a cytidine analog being investigated to treat COVID-19.

N41mab-vcMMAE

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy